Schizophrenie

[1]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[2]  David Keator,et al.  A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. , 2002, The American journal of psychiatry.

[3]  J. Cohen,et al.  Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. , 2001, The American journal of psychiatry.

[4]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Braus,et al.  Aktueller Überblick über strukturelle Magnet-resonanztomographie bei Schizophrenie , 2001 .

[6]  M. Keshavan,et al.  Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part II , 2000, Biological Psychiatry.

[7]  P. Falkai,et al.  Genetik schizophrener Störungen Neuere Konzepte und Befunde , 1999, Der Nervenarzt.

[8]  L. DeLisi,et al.  Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. , 1999, The American journal of psychiatry.

[9]  R. Smith,et al.  Stability of neurological soft signs in chronically hospitalized schizophrenic patients. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[10]  J. Schulenburg,et al.  Die direkten und indirekten Kosten der Schizophrenie , 1999 .

[11]  B. Barraclough,et al.  Excess mortality of mental disorder , 1998, British Journal of Psychiatry.

[12]  M. Isohanni,et al.  Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. , 1998, The American journal of psychiatry.

[13]  G. Bartzokis,et al.  The vulnerability/stress model of schizophrenic relapse: a longitudinal study , 1994, Acta psychiatrica Scandinavica. Supplementum.

[14]  J. Kleinman,et al.  Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. , 1993, Archives of general psychiatry.

[15]  C. Waternaux,et al.  One hundred years of schizophrenia: A meta-analysis of the outcome literature , 1993, Schizophrenia Research.

[16]  J. Lieberman,et al.  Duration of psychosis and outcome in first-episode schizophrenia. , 1992, The American journal of psychiatry.

[17]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[18]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[19]  A. Jablensky.  Epidemiology of schizophrenia: the global burden of disease and disability , 2000, European Archives of Psychiatry and Clinical Neuroscience.

[20]  R. Heinrichs,et al.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.

[21]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[22]  H. Meltzer,et al.  Biological studies in schizophrenia. , 1987, Schizophrenia bulletin.